期刊文献+

2010-2011年中国肺炎链球菌耐药性和血清型研究 被引量:32

Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from multicenters across China,2010--2011
原文传递
导出
摘要 目的了解我国肺炎链球菌的耐药性和血清型分布,为合理使用抗生素和免疫预防提供依据。方法收集2010-2011年我国10个城市13家医院临床分离的非重复性肺炎链球菌471株,采用琼脂稀释法测定15种抗生素的MIC值;采用简易棋盘式肺炎链球菌分型系统和荚膜肿胀实验进行血清型鉴定。结果全部菌株中对青霉素耐药(口服折点,MIC〉t2mg/L)的肺炎链球菌(PRSP)占50.1%(236/471)。对左氧氟沙星和莫西沙星的耐药率分别为1.5%(7/471)和0.6%(3/471)。对阿莫西彬克拉维酸、头孢克洛、头孢呋辛和头孢曲松4种β-内酰胺类药物的耐药率分别为27.4%(129/471)、60.3%(284/471)、58.8%(277/471)和18.5%(87/471)。对红霉素、克林霉素、四环素、磺胺甲嗯唑/甲氧苄啶和氯霉素的耐药率分别为93.2%(439/471)、88.7%(417/471)、89.6%(422/471)、62.8%(296/471)和22.1%(104/471)。471株肺炎链球菌中常见的血清型依次为19F(112,23.8%)、19A(63,13.4%)、3(48,10.2%)、14(43,9.1%)、23F(29,6.2%)、15(25,5.3%)及6A(23,4.9%)。19F与19A血清型中PRSP感染的发生率高达82.1%(100/122)和92.1%(58/63)。7价和13价结合疫苗对所有菌株的覆盖率分别为45.3%(213/471)和76.0%(358/471)。儿童中7价和13价结合疫苗的覆盖率为59.0%(72/122)和86.9%(106/122),成人中为42.3%(94/222)和73.4%(163/222)。结论肺炎链球菌对红霉素、克林霉素及四环素耐药严重。血清型19A和19F耐药严重。7价和13价结合疫苗在儿童中的覆盖率均高于成人。13价结合疫苗可覆盖大部分菌株,特别是PRSP。 Objective To investigate the trends of resistance of S. pneumoniae and to evaluate the potential coverage of pneumococcal conjugate vaccine. Methods The antibiotic susceptibility and serotype distribution of 471 pneumococcal strains isolated from pneumococcal diseases in 13 hospitals across China during 2010 to 2011 were studied. In vitro susceptibility to 15 antimicrobial agents was determined by agar dilution method. Serotyping of S. pneumoniae was performed by using latex and quelling reaction. Vaccine coverage by 7-, 10-, 13-and 23- valent conjugate vaccines was estimated by calculating the percentage of isolates that belonged to the serotypes included in the vaccines. Results Among all strains tested, 50. 1% (236/471) was resistant to penicillin ( Oral breakpoint, MIC 〉1 2 mg/L) . Overall, 27.4% ( 129/471 ) , 60. 3% (284/471), 58.8% (277/471) and 18.5% (87/471) of S. pneumoniae were resistant to amoxicillin/elavulanate, cefaclor, eefuroxime and eeftriaxone, respectively. 1.5 % (7/471) of all stains were resistant to levofloxaein and 0. 6% (3/471) of all strains were resistant to moxifloxacin. The resistance rates to other antibiotic agents, such as erythromycin, clindamycin, tetracycline, trimethoprim/sulfamethoxazole, and chloramphenicol, were 93.2% ( 439/471 ), 88.7% (417/471), 89.6% ( 422/471 ), 62. 8% (296/471) and 22. 1% ( 104/471 ), respectively. The most prevalent serotype was 19F( 112,23.8% ), followed by 19A(63,13.4% ), 3(48,10. 2% ), 14(43,9. 1% ), 23F(29,6.2% ), 15(25,5.3% )and 6A (23,4. 9% ). The potential coverage by 7- and 13-valent pneumococcal conjugate vaccines was 45.3%(213/471) and 76% (358/471), respectively. The potential coverage of PCV7 and PCV13 in children were 59.0% (72/122) and 86. 9% (106/122), and the potential coverage of PCV7 and PCV13 in adult were 42. 3% (94/222) and 73.4% (163/222). Conclusions The antibiotic resistance of S. pneumoniae was serious in China, especially to tetracycline, erythromycin and clindamycin. The majority of serotypes 19A and 19F was penicillin-resistant. The potential coverage of PCV7 and PCV13 in children was higher than those in adult. PCV13 could cover most of the isolates, especially for penicillin-resistant S. pneumoniae.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2013年第2期106-112,共7页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 教育部新世纪优秀人才支持计划(NCET-10-0205)
关键词 肺炎链球菌感染 抗药性 血清分型 Pneumococcal infections Drug resistance Serotyping
  • 相关文献

参考文献14

  • 1O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of diseasecaused by Streptococcus pneumoniae in children younger than 5years : global estimates. Lancet ,2009,374 : 893-902.
  • 2Henrichsen J. Six newly recognized types of Streptococcuspneumoniae. J Clin Microbiol, 1995 ,33 :2759-2762.
  • 3Hausdorff WP, Feikin DR, Klugman KP. Epidemiologicaldifferences among pneumococcal serotypes. Lancet Infect Dis,2005,5:83-93.
  • 4姚开虎,陆权,邓力,俞桑洁,张泓,邓秋莲,佟月娟,高薇,袁林,沈叙庄,杨永弘.2000-2002年三家儿童医院分离的肺炎链球菌血清型分布及其对β内酰胺类抗生素敏感性的变化[J].中华儿科杂志,2006,44(12):928-932. 被引量:15
  • 5姚开虎,王立波,赵根明,郑跃杰,邓力,赵瑞珍,邓秋莲,胡英惠,俞桑洁,沈叙庄,杨永弘.北京上海广州深圳4家儿童医院肺炎住院患儿肺炎链球菌分离株的血清型分布[J].中国循证儿科杂志,2008,3(6):426-432. 被引量:36
  • 6Performance Standards for Antimicrobial Susceptibility Testing;Twenty-first Informational. Supplement. CLSI document M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute,2011.
  • 7Hausdorff WP, Bryant J, Paradiso PR, et al. Whichpneumococcal serogroups cause the most invasive disease :implications for conjugate vaccine formulation and use,part I.Clin Infect Dis,2000 ,30 : 100-121.
  • 8Ozdemir B,Beyazova U,Camurdan AD,et al. Nasopharyngealcarriage of Streptococcus pneumoniae in healthy Turkish infants. JInfect,2008,56:332-339.
  • 9Adam HJ, Karlowsky JA, Nichol KA, et al. Baselineepidemiology of Streptococcus pneumoniae serotypes in Canadaprior to the introduction of the 13-valent pneumococcal vaccine.Microb Drug Resist,2012,18 : 176-182.
  • 10Lauderdale TL, Wagener MM, Lin HM, et al. Serotype andantimicrobial resistance patterns of Streptococcus pneumoniaeisolated from Taiwan Residents children : comparison of nasopharyngealand clinical isolates. Diagn Microbiol Infect Dis, 2006,56: 421-426.

二级参考文献41

  • 1姚开虎,陆权,邓力,俞桑洁,张泓,邓秋莲,沈叙庄,杨永弘.2000—2002年北京、上海和广州儿童肺炎链球菌携带及抗生素耐药性监测[J].中华医学杂志,2005,85(28):1957-1961. 被引量:61
  • 2姚开虎,杨永弘.中国儿童肺炎链球菌疾病研究回顾[J].中国计划免疫,2005,11(6):504-509. 被引量:10
  • 3汪玲,陆权,王传清,邓秋莲,刘岚,甄景慧,张泓,王艺,黄勇,陈沅,杨永弘,沈叙庄.2000~2004年京沪穗渝5家儿童医院革兰阳性球菌耐药情况分析[J].中国循证儿科杂志,2006,1(2):113-121. 被引量:36
  • 4Liu Y, Wang H, Chen MJ, et al. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneurnoniae isolated from children in China younger than 5 years[J]. Diagn Microbiol Infect Dis, 2008, 61(3):256-263.
  • 5Yao KH, Yang YH. Streptococcus pneumoniae diseases in Chinese Children: past, present and future [J]. Vaccine, 2008, 26(35): 4425-4433.
  • 6Jacobs MR, Felminghaum D, Appelbaum PC, et al. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community aepuired respiratory tract infection to commonly used antimicrobial agents[J]. 2003, 52(2): 229-246.
  • 7Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: eighteenth information supplement. M100-S18. Clinical and Laboratory Standards Institute[S]. Wayne, PA, USA 2008.
  • 8Kashiwagi Y. A 23-year longitudinal study on the antibiotic sensitivities of group A streptococci from the scarlet fever patients-1956-1978 [J]. Kansenshogaku Zasshi, 1991, 65(7): 820-832.
  • 9Felmingham D. Comparative antimicrobial susceptibility of respiratory tract pathogens [J]. Chemotherapy, 2004, 50 (S1) :3-10.
  • 10Schoening TE, Wagner J, Arvand M. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany [J]. Clin Microbiol Infect, 2005, 11(7) : 579-582.

共引文献74

同被引文献343

引证文献32

二级引证文献2409

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部